Pfizer’s sasanlimab combo significantly improves event-free survival in BCG-naïve, high-risk non-muscle invasive bladder cancer: New York Tuesday, April 29, 2025, 14:00 Hrs [IS ...

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

The global asset management industry reached a record $128 trillion in assets under management in 2024, a 12% increase over ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $300.9, a high estimate of ...

Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1 ...

As demand continued to recover, Accor's debt/adjusted EBITDA reached 3.9 times in 2022, 2.5 times in 2023, and 2.8 times in 2024. In 2023, Fitch Ratings upgraded Accor's debt to investment-grade.

Baron International Growth Fund gained 0.71% during Q1 2025. Who were the top leaders and laggards? Click here to find out.

AUA annual meeting featured the IBCG Bladder Cancer Forum evaluating common problems and controversies in bladder cancer, moderated by Dr. Laura Mertens, with a debate between Drs. Joshua Meeks and ...

In mergers and acquisitions, CFOs must identify whether payments are contingent consideration or postacquisition compensation to inform financial reporting.

NEW YORK, April 23, 2025--Pfizer Inc. (NYSE: PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American Society of Clinical Oncology (ASCO ...

Showcase your company news with guaranteed exposure both in print and online Network with our region's hottest startups! Pittsburgh Inno presents the Startups to Watch event… The Future of Bay ...